Use of a monoclonal antibody (B72.3) as a novel immunohistochemical adjunct for the diagnosis of carcinomas in fine needle aspiration biopsy specimens-Reference-Cited by-同舟云学术

Use of a monoclonal antibody (B72.3) as a novel immunohistochemical adjunct for the diagnosis of carcinomas in fine needle aspiration biopsy specimens

Published:1986-05 Issue:5 Volume:17 Page:501-513
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Johnston William W.,Szpak Cheryl A.,Lottich S. Chace,Thor Ann,Schlom Jeffrey

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference19 articles.

1. Cancer immunology: the search for specificity;Old;Cancer Res,1981

2. Continuous cultures of fused cells secreting antibody of pre-defined specificit;Kohler;Nature,1975

3. The potential value of immunoperoxidase techniques in diagnostic cytology;Nadji;Acta Cytol,1980

4. Expression of a melanoma tumor associated antigen as demonstrated by a monoclonal antibody (D6.1) in cytopathologic preparations of human tumor cells from effusions and needle aspirates;Johnston;Anal Quant Cytol,1985

5. A spectrum of monoclonal antibodies reactive with mammary tumor cells;Colcher;Proc Natl Acad Sci,1981

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-Trastuzumab;American Journal of Clinical Oncology;2018-07

2. Identification of an antibody fragment specific for androgen-dependent prostate cancer cells;BMC Biotechnology;2014-09-03

3. Tumor-associated glycoprotein 72 (TAG-72) expression in salivary gland neoplasia: an immunohistochemical study using the monoclonal antibody (MAb) CC49;Oral Diseases;2008-06-28

4. Expression of TAG-72 in ovarian cancer and its correlation with tumor stage and patient prognosis;Cancer Letters;2007-06

5. Phase I Study of 90Y-CC49 Monoclonal Antibody Therapy in Patients with Advanced Non-Small Cell Lung Cancer: Effect of Chelating Agents and Paclitaxel Co-Administration;Cancer Biotherapy and Radiopharmaceuticals;2005-10